Society Pass Incorporated. (SOPAQ) Stock Price & Analysis

Society Pass Incorporated. (SOPAQ) fell 33.33% to USD 0 as of September 8, 2026 at 07:35 UTC, according to Nexqual real-time market data.

SOPAQ last closed at USD 0; the session ranged USD 0–0 on volume of 32 shares. Market capitalization is —, with a 52-week range of USD 0–6.28 (PNK). Source: Nexqual, September 8, 2026 at 07:35 UTC.

Key Statistics (as of September 8, 2026 at 07:35 UTC)

PriceUSD 0
Change▼ 33.33% (down)
Previous CloseUSD 0
OpenUSD 0
Day RangeUSD 0 – 0
52-Week RangeUSD 0 – 6.28
Volume32 shares
Market Cap
ExchangePNK

Technical Analysis (SOPAQ)

Nexqual's technical model rates SOPAQ "SELL" based on 1 bullish and 5 bearish signals across 129 daily candles, as of September 8, 2026 at 07:35 UTC.

Overall SignalSELL
RSI (14)45.68 (neutral)
vs SMA50Below (USD 0.01)
MACD-0 (negative)

Earnings (SOPAQ)

Revenue Estimate$1.41M

Recent Earnings History

QuarterActual vs Estimate
2025-09-30USD -0.8 vs est -0.07 ▼ miss
2025-06-30USD 0.1 vs est -0.24 ▲ beat
2025-03-31USD -0.44 vs est -0.13 ▼ miss
2024-12-31USD -1.18 vs est -0.33 ▼ miss

Source: Nexqual, September 8, 2026 at 07:35 UTC.

Financials & Fundamentals (SOPAQ)

Total Revenue$7.23M
Revenue Growth (YoY)-17.60%
Gross Margin+45.75%
Operating Margin-379.94%
Profit Margin-146.00%
ROE-153.37%
Debt / Equity7.23
Current Ratio1.41
Total Cash$14.91M
Total Debt$963,204
Free Cash Flow$-8.04M

Source: Nexqual, September 8, 2026 at 07:35 UTC.

Ownership (SOPAQ)

Insider Ownership+3.59%
Institutional Ownership+0.00%
Shares Outstanding12.87M
Float5.70M
Short % of Float+6.86%

Source: Nexqual, September 8, 2026 at 07:35 UTC.

From Society Pass Incorporated.'s Latest SEC 10-K Filing (filed 2025-04-16)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
BFRIBiofrontera Inc.USD 1.61▲ 5.92%
ISPCiSpecimen Inc.USD 1.54▲ 3.36%
KTTAPasithea Therapeutics Corp.USD 0.58▲ 0%
PTPIPetros Pharmaceuticals, Inc.USD 0.01▲ 20%
ENSCEnsysce Biosciences, Inc.USD 0.46▲ 2.93%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:35 UTC. This page is informational and not investment advice.